Strategies for Cure in Newly Diagnosed Multiple Myeloma

新诊断的多发性骨髓瘤的治疗策略

• 批准号: 7725599
• 负责人: BART BARLOGIE
• 金额: $ 145.25万
• 依托单位: UNIV OF ARKANSAS FOR MED SCIS
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2014-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7725599
• 关键词: Adopted; Biology; Biopsy; Bone Marrow; Bortezomib; Cell Line; Cells; Chromosome abnormality; Clinical; Clinical Trials; Combined Modality Therapy; Consolidation Therapy; Data; Diagnosis; Disease; Disease remission; Disease-Free Survival; Dose; Drug Combinations; Drug resistance; Event; Evolution; Exposure to; Follicular Lymphoma; Funding; Future; Gene Expression; Gene Expression Profiling; Genomic Instability; Grant; Growth; Hereditary Disease; Human; Image; Individual; Institution; Instruction; Intervention; Investigation; Length; Lesion; Link; Lymphoma; Magnetic Resonance Imaging; Maintenance; Malignant Neoplasms; Melphalan; Modeling; Molecular; Molecular Abnormality; Molecular Profiling; Monoclonal Antibodies; Monoclonal gammopathy of uncertain significance; Morbidity - disease rate; Mucositis; Multiple Myeloma; Newly Diagnosed; Osteolytic; Outcome; Pathway interactions; Patients; Pharmaceutical Preparations; Pharmacogenomics; Phase; Phase II Clinical Trials; Phase III Clinical Trials; Placenta; Plasma Cells; Population; Program Research Project Grants; Protocol Compliance; Protocols documentation; Recovery; Recurrence; Recycling; Relapse; Remission Induction; Research; Resistance; Resolution; Resources; Risk; Roentgen Rays; Safety; Sampling; Signal Transduction; Site; Specific qualifier value; Subgroup; Survival Rate; Survivors; Testing; Thalidomide; Therapeutic; Therapeutic Human Experimentation; Therapeutic Intervention; Time; Toxic effect; Translational Research; Transplantation; Treatment Failure; Treatment Protocols; Vertebral column; base; beneficiary; bone; disorder risk; effective therapy; exhaustion; follow-up; high risk; improved; insight; novel; osteoblast differentiation; outcome forecast; prevent; prognostic; repository; resistance mechanism; response; success; tool; treatment strategy; trial comparing; tumor